2020 Election with Avalere: What’s at Stake for Healthcare Post-Election?

Summary

Avalere experts discussed how the 2020 election is influencing the future of healthcare.

Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Access Recording

COVID-19, the Affordable Care Act (ACA), and drug-pricing reform have taken center stage in the healthcare debate this past year. Join our experts to find out how the 2020 election could bring about major changes influencing the future of healthcare. This includes implications of a Biden administration or second-term Trump presidency, and an assessment of the new composition of the Senate.

Key Topics

COVID-19
ACA
Drug-pricing reform
Medicare and Medicaid
Healthcare disparities

Panelists

Moderator

Matt Kazan , Managing Director, Policy

Matt Kazan advises health plans, life sciences clients, and patient organizations as they navigate the policy landscape, focusing on Medicare Part D and Medicare Advantage, and implementation of the Inflation Reduction Act.

Speaker

Dan Mendelson , Founder

Dan Mendelson is Founder and former CEO of Avalere Health, a vibrant community of innovative thinkers dedicated to solving the challenges of the healthcare system.

Speaker

Chris Sloan

Chris Sloan advises a number of clients, including pharmaceutical manufacturers, health plans, providers, and patient groups on key policy issues facing the healthcare industry.